Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 648

1.

History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.

Herr HW, Morales A.

J Urol. 2008 Jan;179(1):53-6. Epub 2007 Nov 13.

PMID:
17997439
2.

Re: History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story: H. W. Herr and A. Morales. J Urol 2008; 179: 53-56.

Koyama A.

J Urol. 2008 Nov;180(5):2255; author reply 2255. doi: 10.1016/j.juro.2008.07.081. Epub 2008 Sep 27. No abstract available.

PMID:
18823917
3.

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

Böhle A, Brandau S.

J Urol. 2003 Sep;170(3):964-9. Review.

PMID:
12913751
4.

Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.

Lerner SP, Tangen CM, Sucharew H, Wood D, Crawford ED.

J Urol. 2007 May;177(5):1727-31.

PMID:
17437798
5.

Long term protection in bladder cancer following intralesional immunotherapy.

Reichert DF, Lamm DL.

J Urol. 1984 Sep;132(3):570-3.

PMID:
6381762
6.

Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guérin (BCG) immunotherapy exist?. analysis of a quarter century of literature.

Saint F, Salomon L, Quintela R, Cicco A, Hoznek A, Abbou CC, Chopin DK.

Eur Urol. 2003 Apr;43(4):351-60; discussion 360-1. Review.

PMID:
12667715
7.

Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

Decobert M, Larue H, Bergeron A, Harel F, Pfister C, Rousseau F, Lacombe L, Fradet Y.

J Urol. 2006 Apr;175(4):1506-11.

PMID:
16516037
8.

An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.

Berglund RK, Savage CJ, Vora KC, Kurta JM, Cronin AM.

J Urol. 2008 Oct;180(4):1297-300; discussion 1300. doi: 10.1016/j.juro.2008.06.034. Epub 2008 Aug 15.

PMID:
18707737
9.

Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Piñeiro L, Gonzalez M, Portillo J, Ojea A, Pertusa C, Rodriguez-Molina J, Camacho JE, Rabadan M, Astobieta A, Montesinos M, Isorna S, Muntañola P, Gimeno A, Blas M, Martinez-Piñeiro JA.

J Urol. 2009 Nov;182(5):2195-203. doi: 10.1016/j.juro.2009.07.016. Epub 2009 Sep 16.

PMID:
19758621
10.

Prognostic value of p53 overexpression in bladder tumors treated with Bacillus Calmette-Guerin.

Peyromaure M, Ravery V.

Expert Rev Anticancer Ther. 2002 Dec;2(6):667-70.

PMID:
12503212
11.

The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study.

Pan CW, Shen ZJ, Ding GQ.

J Urol. 2008 Apr;179(4):1307-11; discussion 1311-2. doi: 10.1016/j.juro.2007.11.045. Epub 2008 Mar 4.

PMID:
18289576
12.

[Immunotherapy in superficial bladder carcinoma].

Ríos González E, Martínez-Piñeiro Lorenzo L, Martínez-Piñeiro Caramés JA, de la Peña Barthel JJ.

Arch Esp Urol. 2000 Dec;53(10):879-92. Review. Spanish.

PMID:
11213392
13.
14.

[Calmette-Guerin bacillus disseminated infection after intravesical instillation].

Borré S, Brustia D, Rosa F, Brondolo R, Rizzo G, Garavelli PL.

Recenti Prog Med. 2002 Apr;93(4):247-8. Review. Italian.

PMID:
11989131
15.

Anti-angiogenic effects of the superantigen staphylococcal enterotoxin B and bacillus Calmette-Guérin immunotherapy for nonmuscle invasive bladder cancer.

Reis LO, Ferreira U, Billis A, Cagnon VH, Fávaro WJ.

J Urol. 2012 Feb;187(2):438-45. doi: 10.1016/j.juro.2011.10.022. Epub 2011 Dec 15.

PMID:
22177150
16.

Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor.

Kadhim SA, Chin JL, Batislam E, Karlik SJ, Garcia B, Skamene E.

J Urol. 1997 Aug;158(2):646-52.

PMID:
9224385
18.

Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study.

Cai T, Nesi G, Tinacci G, Zini E, Mondaini N, Boddi V, Mazzoli S, Bartoletti R.

J Urol. 2008 Jul;180(1):110-5. doi: 10.1016/j.juro.2008.03.038. Epub 2008 May 15.

PMID:
18485394
19.

Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.

Yossepowitch O, Eggener SE, Bochner BH, Donat SM, Herr HW, Dalbagni G.

J Urol. 2006 Aug;176(2):482-5.

PMID:
16813873
20.

Defining bacillus Calmette-Guerin refractory superficial bladder tumors.

Herr HW, Dalbagni G.

J Urol. 2003 May;169(5):1706-8.

PMID:
12686813

Supplemental Content

Support Center